Alpha1-and beta2-adrenoceptors in the human liver with mass-forming intrahepatic cholangiocarcinoma: Density and coupling to adenylate cyclase and phospholipase C

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 372, Issue 3, 2005, Pages 171-181

  Kassahun, W T ^a   Gunl B ^a   Tannapfel, A ^a   Ungemach, F R ^a   Hauss, J ^a   Abraham, G ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Adrenoceptors; Catecholamine; Cholangiocarcinoma; Liver tumour

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; ADENYLATE CYCLASE; ALPHA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CYANOIODOPINDOLOL; FLUORIDE SODIUM; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; NORADRENALIN; PHOSPHOLIPASE C; PRAZOSIN; RECEPTOR SUBTYPE; TRITIUM; UNCLASSIFIED DRUG; CA 19-9 ANTIGEN; PROPANOLAMINE DERIVATIVE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BINDING AFFINITY; CANCER INVASION; CARCINOGENESIS; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENCY; ENZYME ACTIVITY; ENZYME SUBSTRATE COMPLEX; FEMALE; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; LIVER; LIVER CANCER; LIVER METABOLISM; MALE; PROTEIN BINDING; QUANTITATIVE ANALYSIS; RECEPTOR BINDING; RECEPTOR DENSITY; STATISTICAL SIGNIFICANCE; BLOOD; CLINICAL TRIAL; DRUG EFFECT; ENZYMOLOGY; LIVER TUMOR; METABOLISM; PATHOLOGY;

ADENYLATE CYCLASE; ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; CA-19-9 ANTIGEN; CHOLANGIOCARCINOMA; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; PHOSPHOLIPASE C; PROPANOLAMINES; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, BETA-2;

EID: 27944453139     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-005-0017-2     Document Type: Article

References (61)

1. Abraham G, Kottke C, Dhein S, Ungemach FR (2003). Pharmacological and biochemical characterization of the beta-adrenergic signal transduction pathway in different segments of the respiratory tract. Biochem Pharmacol 66:1067-1081
2. Benchekroun LE, Couton D, Postic C et al. (2005). Overexpression of β2-adrenergic receptors in mouse liver alters the expression of glyconeogenic and glycolytic enzymes. AJP-Endocrinol Metab 288:E715-E722
3. Bevilacqua M, Norbiato G, Chebat E et al (1991). Changes in alpha-1 and beta-2 adrenoceptor density in human hepatocellular carcinoma. Cancer 67:2543-2551
4. Bilski AJ, Halliday SE, Fitzgerald (1983). The pharmacology of a beta 2-selective adrenoceptor antagonist (ICI 118,551). J Cardiovasc Pharmacol 5:430-437
5. Brodde OE (1991). Beta1 and beta2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43:203-242
6. Cho-Chung YS (1988). Models of tumour regression in endocrine-related cancer. In: Stoll BA(ed). Endocrine management of cancer. Biological Bases. Karger, Basel, pp 1-13
7. Daza JF, Parrilla R, Martin-Requro A (1997). Influence of thyroid status on hepatic alpha 1-adrenoceptor responsiveness. Am J Physiol 273:E1065-E1072
8. De Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM (1999). Biliary tract cancers. N Engl J Med 341:1368-1378
9. Dennis JW, Laferte S (1985). Recognition of asparagine-linked oligosaccharides on murine tumour cells by natural killer cells. Cancer Res 6034-6040
10. Dooley DJ, Bittiger H, Reymann NC (1986). CGP 20712 A: a useful tool for quantitating beta 1-and beta 2-adrenoceptors. Eur J Pharmacol 130:137-139
11. Draoui A, Vandewalle B, Hornez L, Revillion F, Lefebvre J (1991). β-adrenergic receptors in human breast cancer: identification, Characterization and Correlation with progestron and estradiol receptors. Anticancer Res 11:677-680
12. El-Rafai MF, Chan TM (1984). Evidence of heterogeneous distribution of alpha1 and beta-adrenergic binding sites on rat-liver cell surface. Biochim Biophys Acta 775:356-364
13. Guellaen G, Yates-Aggerbeck M, Vauquelin G, Strosberg D, Hanoune J (1978). Characterization with [3H] dihydroergocryptine of the alpha-adrenergic receptor of the hepatic plasma membrane. Comparison with the beta-adrenergic receptor in normal and adrenalectomized rats. J Biol Chem 253:1114-1120
14. Gangopadhyay A, Lazure DA, Thomas P (1998). Adhesion of colorectal carcinoma cells to the endothelium is mediated by cytokines from CEA stimulated Kupffer cells. Clin Exp Metastasis 16:703-712
15. Gangopadhyay A, Bajenova O, Kelly TM, Thomas P (1996). Carcinoembryonic antigen induces cytokine expression in Kupffer cells: implication for hepatic metastasis from colon cancer. Cancer Res 56:4805-4810
16. Garro M, Lopez M, Ruiz I, Callado LF, Meana J, Salles J (2001). Regulation of phospholipase Cβ activity by muscarinic acetylcholine and 5-HT2 receptors in crude and synaptosomal membranes from human cerebral cortex. Neuropharmacology. 40:686-695
17. Hakomori S (1989). Aberrant glycosylation in tumours and tumour-associated carbohydrate antigens. Adv Cancer Res 52:257-331
18. Hemmings SJ, Wilson TR (2003). Lymphosarcoma-induced alterations in hepatic adrenergic receptors: implications to the hypoglycemia of cancer cachexia. Mol Cell Biochem 250:167-177
19. Hoffman BB, Hu ZW (2000). Alpha-1-adrenoceptors and vascular smooth muscle cell growth. Prostate 9:29-33
20. Hoffman BB, Lefkowitz RJ (1982) Agonist interactions with alpha-adrenergic receptors. J Cardiovasc Pharmacol 4:S14-S18
21. Hoffmann C, Leitz MR, Oberdorf-Maass S, Lohse MJ, Klotz KN (2004) Comparative pharmacology of human beta-adrenergic receptor subtypes- characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedeberg's Arch Pharmacol 365:151-159
22. Hyltander A, Drott C, Korner U, Sandstrom R, Lundholm K (1991) Elevated energy expenditure in cancer patients with solid tumours. Eur J Cancer 27:9-15
23. Jard S, Cantau B, Jakobs KH (1981). Angiotensin II and alpha-adrenergic agonists inhibit rat liver adenylate cyclase. J Biol Chem 256:2603-2606
24. Katsanos KH, Kistanou M, Christodoulou DK, Tsianos EV (2002). High CA 19-9 levels in benign biliary tract diseases. Report of four cases and review of the literature. Eur J Intern Med 13:132-135
25. Kawai Y, Powell A, Arinze IJ (1986). Adrenergic receptors in human liver plasma membranes: predominance of β2-and α1-receptor subtypes. JCE and M 62:827-832
26. Kleene R, Berger EG (1985). The molecular and cell biology of glycosyltransferases. Biochim Biophys Acta 1154:283-325
27. Kost DP, DeFrances MC, Lee CR, Michalopoulos GK (1992). Patterns of alpha-1-adrenergic receptor expression in regenerating and neoplastic hepatic tissue. Pathobiology 60:303-308
28. Kunos G, Ishac EJ, Gao B, Jiang L (1995). Inverse regulation of hepatic alpha 1B-and beta 2-adrenergic receptors. Cellular mechanisms and physiological implications. Ann N Y Acad Sci 757:261-271
29. Kuusela P, Haglund C, Roberts PJ (1991). Comparison of a new tumour marker CA 242 with CA19-9, CA50 and carcinoembryonic antigen (CEA) in digestive tract diseases. Br J Cancer 63:636-640
30. Kyprianou N, Chon J, Benning CM (2000). Effects of alpha-1-adrenoceptor antagonists on cell proliferation and apoptosis in the prostate: therapeutic implications in prostate disease. Prostate 9:42-46
31. Labarba RC (1970). Experimental and environmental factors in cancer. Psychosom Med 32:259-276
32. Langhans W (2003). Role of the liver in the control of glucose-lipid utilization and body weight. Curr Opin Clin Nutr Metab Care 6:449-455
33. Lin J, Yan F, Hu S, Ju H (2004). Chemiluminescent immunosensor for CA 19-9 based on antigen immobilization on a cross-linked chitosan membrane. JIM 291:165-174
34. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951). Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275
35. Magnani JL, Steplewski Z, Koprowski H, Ginsburg V (1983). Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res 43:5489-5492
36. Maitra SR, Wojnar MM, Lang CH (2000). Alterations in tissue glucose uptake during the hyperglycaemic and hypoglycaemic phases of sepsis. Eur J Intern Med 13:379-385
37. Malbon CC (1980). Liver cell adenylate cyclase and β-adrenergic receptors: increased β-adrenergic receptor number and responsiveness in the hypothyroid rat. J Biol Chem 255:8692-8699
38. Marchetti B, Paulain M, Labrie F (1988). Castration levels of plasma testosterone have potent stimulatory effects on androgen sensitive parameters on the rat prostate. J Steroid Biochem 31:411-418
39. Marchetti B, Coini M, Badr M, Follea N, Pelletier G (1987). Ovarian adrenergic nerves directly participate in the control of LHRH and β-adrenergic receptors during a puberty: a biochemical and autoradiographic study. Endocrinology 121:219-226
40. Marchetti B, Spinola PG, Pelletier G, Labrie F (1991). A potential role for catecholamines in the development and progression of carcinogen-induced mammary tumours: hormonal control of β-adrenergic receptors and correlation with tumour growth. J Steroid Biochem Molec Biol 38:307-320
41. Nagino M, Nimura Y, Kamiya J et al (1998). Segmental liver resections for hilar cholangiocarcinoma. Hepatogastroenterology 45:7-13
42. Nakeeb A, Pitt HA, Sohn TS et al (1996). Cholangiocarcinoma: a spectrum of intrahepatic, perihilar and distal tumours. Ann Surg 224:463-473
43. Nicolson GL (1982). Cancer metastases. Organ colonization and the cell-surface properties of malignant cells. Biochim Biophys Acta 695:113-176
44. Patel T (2001). Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33:1353-1357
45. Patel AH, Harnois DM, Klee GG, La Russo NF, Gores GJ (2000). The utility of CA 19-9 in the diagnosis of cholangiocarcinoma in patients without sclerosing cholangitis. Am J Gastroenterol 95:204-220
46. Poyet P, Labrie F (1986). Characterization of β-adrenergic receptors in dispersed rat Leydig cells. J Androl 8:7-12
47. Robinson IA, McKee G, Kissin MW (1995). Typing and grading breast carcinoma on fine needle aspiration: is this clinically useful information? Diagn Cytopathol 13:260-265
48. Salomon Y, Londos C, Rodbell M (1974). A highly sensitive adenylate cyclase assay. Anal Biochem 58:541-548
49. Sarsero D, Russell FD, Lynham JA, Rabnott G, Yang I, Fong KM, Li L, Kaumann AJ, Molenaar P (2003). (-)-CGP 12177 increases contractile force and hastens relaxation of human myocardial preparations through a propranolol-resistant state of the beta1-adrenoceptor. Naunyn-Schmiedeberg's Arch Pharmacol 367:10-21
50. Schmelck PH, Hanoune J (1980). The hepatic adrenergic receptors. Mol Cell Biochem 33:35-48
51. Seamon KB, Daly JW (1986). Forskolin: its biological and chemical properties. Adv Cyclic Nucleotide Protein Phosphorylation Res 20:1-150
52. Shavit Y, Terman GW, Martin FC, Lewis JW, Liebeskind JC, Galle RP (1985). Stress, opioid peptides, the immune system and cancer. J Immun 135:834-837
53. Snell K, Evans CA (1988). Characterization of rat liver beta-adrenoceptors during prenatal development as determined by 125I-iodopindolol radioligand binding essays. Br J Pharmacol 93:817-826
54. Stevens DP, Mackay IR (1973). Increased carcinoembryonic antigen in heavy cigarette smokers. Lancet 2:1238-1239
55. Suh Y (2002). Cell signalling in aging and apoptosis. Mech Ageing Dev 23:881-890
56. Thomas AP, Renard-Rooney DC, Hajnoczky G, Rob-Gaspers LD, Lin C, Rooney TA (1995). Subcellular organization of calcium signalling in hepatocytes and the intact liver. Ciba Found Symp 188:18-49
57. Wolfe BB, Harden TK, Molinoff PB (1976). Beta-adrenergic receptors in rat liver: effects of adrenalectomy. Proc Natl Acad Sci U S A 73:1343-1347
58. Wu T, Han C, Lunz JG, Michlopoulos G, Shelhamer JH, Demetris AJ (2002). Involvement of 85-kd cytosolic phospholipase A2 and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells. Hepatology 36:363-373
59. Yamatani K, Saito K, Takahashi K, Ohnuma H, Manaka H, Sasaki H (2001). Hormon-specific combinations of isoforms of adenylyl cyclase and phosphodiesterase in the rat liver. Regul Pept 99:45-52
60. Zeiders JL, Seidler FJ, Slotkin TA (1999). Agonist-induced sensitization of beta-adrenoceptor signalling in neonatal rat heart: expression and catalytic activity of adenylyl cyclase. J Pharmacol Exp Ther 291:503-510
61. 2 -adrenoceptors in norepinephrine-induced TNF-α production. Biochem et Biophys Acta 1537:49-57